GLPBio

Neuroscience

Neuroscience(神经科学)

Neuroscience

Neurons communicate with each other, effector organs and sensory organs through the neurotransmitter – receptor pathway at synapses. Neurotransmitters can be divided into 4 major groups: 1. Amino acids (glumate, aspartate, serine, glycine and GABA); 2. Monoamines (norepinephrine, epinephrine, dopamine, histamine, and serotonin); 3. Peptides (opioid peptides, substance P, somatostatin); and 4. Others (acetylcholine, NO, nucleosides). read more

研究方向

Neuroscience 相关产品(3932)

  • GC35428 structure
    GC35428Atropine sulfate
    CAS: 55-48-1
    纯度: >98.00%

    A non- selective muscarinic acetylcholine receptor antagonist

  • GC35432 structure
    GC35432Autocamtide-2-related inhibitory peptide (TFA)
    纯度: >95.00%

    A CaMKII inhibitor

  • GC35443 structure
    GC35443Azaphen
    CAS: 24853-80-3

    Pipofezine(Azafen,Azaphen)是5-羟色胺重吸收抑制剂。

  • GC35444 structure
    GC35444Azaphen dihydrochloride monohydrate
    CAS: 63302-99-8
    纯度: >99.50%

    Pipofezine(Azafen，Azaphen)是5-羟色胺重吸收抑制剂。

  • GC35455 structure
    GC35455BACE1-IN-4
    CAS: 2361157-92-6

    BACE1-IN-4 是一种有效、高度选择性的 BACE1 抑制剂，IC50 值为 3.8 nM，Ki 值为 1.9 nM。抗阿尔滋海默症。

  • GC35471 structure
    GC35471Bavisant
    CAS: 929622-08-2

    Bavisant (JNJ-31001074)是口服活性人H3受体拮抗剂。

  • GC35472 structure
    GC35472Bavisant dihydrochloride
    CAS: 929622-09-3

    Bavisant盐酸盐(JNJ-31001074)是口服活性人H3受体拮抗剂。

  • GC35473 structure
    GC35473Bavisant dihydrochloride hydrate
    CAS: 1103522-80-0
    纯度: >99.50%

    Bavisant dihydrochloride hydrate (JNJ31001074AAC) 是口服活性人H3 受体拮抗剂。

  • GC35492 structure
    GC35492Benzamide Derivative 1
    CAS: 108226-05-7

    Benzamide Derivative 1是来自专利EP0213775A1，化合物18，的苯甲酰胺衍生物。Benzamide Derivative 1可能用于治疗胃肠疾病的研究。

  • GC35493 structure
    GC35493Benzoylgomisin O
    CAS: 130783-32-3

    Benzoylgomisin O 是从 Schisandra rubriflora 中分离的化合物，对 15-LOX、COX-1、COX-2 酶有抑制作用，且具有抗炎活性。

  • GC35524 structure
    GC35524Biperiden
    CAS: 514-65-8

    Biperiden(KL 373)有抗帕金森症活性，是中枢M1胆碱受体阻断剂。

  • GC35538 structure
    GC35538BNC375
    CAS: 1557240-80-8
    纯度: >99.50%

    BNC375 是一种口服有效的选择性 α7nAChRs I 型正向变构调节剂，EC50 为 1.9 μM。

  • GC35564 structure
    GC35564BuChE-IN-TM-10
    CAS: 2313524-95-5

    BuChE-IN-TM-10 (TM-10)是一种有效的丁基胆碱酯酶 (BuChE) 抑制剂，其IC50 值为8.9 nM。BuChE inhibitor 1能够抑制和分解自诱导的Aβ聚合, 表现出强大的抗氧化活性和良好的血脑屏障 (BBB) 渗透性。有治疗阿尔兹海默症的潜能。

  • GC35601 structure
    GC35601CaMKII-IN-1
    CAS: 1208123-85-6
    纯度: >99.50% / >98.00%

    CaMKII-IN-1是一种强效且高度选择性的CaMKII抑制剂，IC 50 值为63nM。

  • GC35610 structure
    GC35610Cariprazine hydrochloride
    CAS: 1083076-69-0
    纯度: >98.50%

    An atypical antipsychotic

  • GC35655 structure
    GC35655Cetirizine D4 dihydrochloride

    Cetirizine D4二盐酸盐是Cetirizine氘代化合物标准品。

  • GC35656 structure
    GC35656Cetirizine D8 dihydrochloride
    CAS: 2070015-04-0

    An internal standard for the quantification of cetirizine,(R)-cetirizine, and (S)-cetirizine

  • GC35669 structure
    GC35669CGP 36742
    CAS: 123690-78-8
    纯度: >98.00%

    A GABA B receptor antagonist

  • GC35720 structure
    GC35720Colivelin TFA
    CAS: 2803948-60-7
    纯度: >95.00%

    A potent STAT3 activator and neuroprotective agent

  • GC35751 structure
    GC35751CS-003 Free base
    CAS: 191672-52-3

    CS-003 Free base (CS-003)是一种三速激肽受体拮抗剂，对人神经激肽 (Neurokinin) NK1，NK2 和 NK3 受体具有高亲和力，Ki 值分别为 2.3 nM，0.54 nM 和 0.74 nM。CS-003 Free base (CS-003) 对与神经激肽有关的呼吸系统疾病具有治疗功效。

  • GC35806 structure
    GC35806Danegaptide
    CAS: 943134-39-2
    纯度: >98.00%

    Danegaptide是一种有效的、选择性的、具有口服活性的间隙连接（gap-junction）修饰剂。

  • GC35807 structure
    GC35807Danegaptide Hydrochloride
    CAS: 943133-81-1
    纯度: >99.00%

    Danegaptide Hydrochloride是一种有效的、选择性的、具有口服活性的间隙连接（gap-junction）修饰剂。

  • GC35810 structure
    GC35810Darifenacin
    CAS: 133099-04-4
    纯度: >98.00%

    Darifenacin HBr (UK-88525) is a selective M3 muscarinic receptor antagonist with pKi of 8.9.

  • GC35820 structure
    GC35820DDD107498 succinate
    CAS: 2444781-71-7
    纯度: >98.50%

    DDD107498 (M-5717, DDD-498) is a P. falciparum translation elongation factor 2 inhibitor. DDD107498 exhibits a potent and novel spectrum of antimalarial activity against multiple life-cycle stages of the Plasmodium parasite.